Razor Genomics

Razor Genomics offers RiskReveal, a molecular stratification test designed to identify patients with stage IA-IIA non-squamous non-small cell lung cancer (NSCLC) who may be at low or high risk of recurrence. The test analyzes the molecular signature of tumor tissue to help oncologists make informed treatment decisions regarding adjuvant therapy. Wi... th a focus on improving patient outcomes, Razor Genomics aims to assist thoracic surgeons and medical oncologists in optimizing post-surgical treatment. The company is committed to providing accessible and affordable testing, accepting all insurance on an out-of-network basis and offering a Patient Assistance Program.Read More